Showing results (601-610 of 1,278) with videos related to

Sort By:
Pageof 128
Archives of Surgery (Chicago, Ill. : 1960)|April 19, 2006
Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studiesAtul A Gawande, Jack M Monchik, Thomas A Abbruzzese, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flowNizar A Mullani, Roy S Herbst, Roger G O'Neil, et al.
Protein and Peptide Letters|September 29, 2012
Type I interferons: ancient peptides with still under-discovered anti-cancer propertiesMichele Caraglia, Alessandra Dicitore, Monica Marra, et al.
Protein Engineering|December 14, 2001
Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A)A M Facchiano, P Stiuso, M L Chiusano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotypeCarmine Carbone, Tania Moccia, Cihui Zhu, et al.
Life Sciences|July 22, 2008
Synergistic effects of multiple natural products in pancreatic cancer cellsZhiwei Wang, Sita Desmoulin, Sanjeev Banerjee, et al.
European Journal of Physical and Rehabilitation Medicine|July 20, 2016
Treadmill training frequency influences walking improvement in subjects with Parkinson's disease: a randomized pilot studyElisa Pelosin, Laura Avanzino, Roberta Barella, et al.
The New England Journal of Medicine|April 27, 1975
Percutaneous aspiration biopsy of the pancreas under ultrasonic guidanceE H Smith, R J Bartrum, Y C Chang, et al.
Neurology|February 1, 1997
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsiesA Schenone, L Nobbio, P Mandich, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinomaR Pazdur, B Bready, J A Ajani, et al.
Pageof 128